{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:38:38Z","timestamp":1761154718984,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.revmed.2004.11.013","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T10:47:41Z","timestamp":1103885261000},"page":"238-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["L'ost\u00e9omalacie oncog\u00e8ne \u00a0: r\u00f4le des phosphatonines. Int\u00e9r\u00eat du dosage du fibroblast growth factor 23 d\u00e9montr\u00e9 chez un malade"],"prefix":"10.1016","volume":"26","author":[{"given":"J.L.","family":"Dupond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Magy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mahammedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Prie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Meaux-Ruault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kantelip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2004.11.013_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathology entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am. Surg. Pathol."},{"key":"10.1016\/j.revmed.2004.11.013_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","article-title":"The phosphatonin pathway : new insights in phosphate homeostasis","volume":"65","author":"SchiavI","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.revmed.2004.11.013_bib3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia. A complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.revmed.2004.11.013_bib4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast Growth Factor in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.revmed.2004.11.013_bib5","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterisation of FGF-23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.revmed.2004.11.013_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF-23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.revmed.2004.11.013_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.revmed.2004.11.013_bib8","first-page":"493","article-title":"A case of oncogenic osteomalacia detected by 111 IN-pentetreotide total body scan","volume":"21","author":"Casari","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"issue":"suppl 1","key":"10.1016\/j.revmed.2004.11.013_bib9","first-page":"25S","article-title":"Acquisition protocol considerations for combined PET\/CT imaging","volume":"45","author":"Beyer","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.revmed.2004.11.013_bib10","first-page":"1747","article-title":"Les ost\u00e9omalacies tumorales hypophosphor\u00e9miques","volume":"14","author":"Koeger","year":"1985","journal-title":"Press Med."},{"key":"10.1016\/j.revmed.2004.11.013_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3346\/jkms.1994.9.4.289","article-title":"Oncogenic osteomalacia. A clinicopathological study of 17 bone lesions","volume":"9","author":"Park","year":"1994","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.revmed.2004.11.013_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/pgmj.61.714.349","article-title":"Oncogenic osteomalacia: strange tumor in strange places","volume":"61","author":"Weiss","year":"1985","journal-title":"Post-Graduate Med. J."},{"key":"10.1016\/j.revmed.2004.11.013_bib13","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th ed","first-page":"33","article-title":"Tumor-induced osteomalacia","author":"Drezner","year":"1999"},{"key":"10.1016\/j.revmed.2004.11.013_bib14","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors\u00a0: a polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2004.11.013_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.revmed.2004.11.013_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.revmed.2004.11.013_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.revmed.2004.11.013_bib18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bone.2003.12.025","article-title":"Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23 producing tumor of the distal ulna","volume":"34","author":"Ward","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.revmed.2004.11.013_bib19","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphoremic rickets-osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.revmed.2004.11.013_bib20","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","article-title":"Venous sampling for Fibroblast Growth Factor 23 confims preoperative diagnosis of tumor-induced osteomalacia","volume":"89","author":"Takeuchy","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.revmed.2004.11.013_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.revmed.2004.11.013_bib22","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemia is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimida","year":"2002","journal-title":"Endocrinology"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304004862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304004862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:12:50Z","timestamp":1759335170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866304004862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0248866304004862"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2004.11.013","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L'ost\u00e9omalacie oncog\u00e8ne \u00a0: r\u00f4le des phosphatonines. Int\u00e9r\u00eat du dosage du fibroblast growth factor 23 d\u00e9montr\u00e9 chez un malade","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2004.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}